Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice
- Autores
- de la Torre, Eulalia; Davel, Lilia; Jasnis, María A.; Gotoh, Tomomi; Sacerdote de Lustig, Eugenia; Sales, María Elena
- Año de publicación
- 2006
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Introduction The role of macrophages in tumor progression has generated contradictory evidence. We had previously demonstrated the ability of peritoneal macrophages from LMM3 murine mammary adenocarcinoma-bearing mice (TMps) to increase the angiogenicity of LMM3 tumor cells, mainly through polyamine synthesis. Here we investigate the ability of the parasympathetic nervous system to modulate angiogenesis induced by TMps through the activation of the muscarinic acetylcholine receptor (mAchR). Methods Peritoneal macrophages from female BALB/c mice bearing a 7-day LMM3 tumor were inoculated intradermally (3 × 105 cells per site) into syngeneic mice. Before inoculation, TMps were stimulated with the muscarinic agonist carbachol in the absence or presence of different muscarinic antagonists or enzyme inhibitors. Angiogenesis was evaluated by counting vessels per square millimeter of skin. The expression of mAchR, arginase and cyclo-oxygenase (COX) isoforms was analyzed by Western blotting. Arginase and COX activities were evaluated by urea and prostaglandin E2 (PGE2) production, respectively. Results TMps, which stimulate neovascularization, express functional mAchR, because carbachol-treated TMps potently increased new blood vessels formation. This response was completely blocked by preincubating TMps with pirenzepine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), M1 and M3 receptor antagonists, and partly by the M2 receptor antagonist methoctramine. M1 receptor activation by carbachol in TMps triggers neovascularization through arginase products because N ω-hydroxy-L-arginine reversed the agonist action. Preincubation of TMps with methoctramine partly prevented carbachol-stimulated urea formation. In addition, COX-derived liberation of PGE2 is responsible for the promotion of TMps angiogenic activity by M3 receptor. We also detected a higher expression of vascular endothelial growth factor (VEGF) in TMps than in macrophages from normal mice. Carbachol significantly increased VEGF expression in TMps, and this effect was totally reversed by methoctramine and pirenzepine. Arginase and COX inhibitors partly decreased VEGF derived from TMps. Conclusion TMps themselves induce a potent angiogenic response that is augmented by carbachol action. mAchR activation triggers arginine metabolism, PGE2 synthesis and VEGF production, promoting neovascularization.
Fil: de la Torre, Eulalia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Davel, Lilia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Jasnis, María A.. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Gotoh, Tomomi. Kumamoto University; Japón
Fil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Sales, María Elena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Unidad documental simple - Materia
-
ADENOCARCINOMA
MACROPHAGES
SACERDOTE INVESTIGADORA
PUBLICACIONES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/122690
Ver los metadatos del registro completo
| id |
CONICETDig_2ebe4fcb6c18cac7b3f21882bb9adea6 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/122690 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing micede la Torre, EulaliaDavel, LiliaJasnis, María A.Gotoh, TomomiSacerdote de Lustig, EugeniaSales, María ElenaADENOCARCINOMAMACROPHAGESSACERDOTE INVESTIGADORAPUBLICACIONEShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Introduction The role of macrophages in tumor progression has generated contradictory evidence. We had previously demonstrated the ability of peritoneal macrophages from LMM3 murine mammary adenocarcinoma-bearing mice (TMps) to increase the angiogenicity of LMM3 tumor cells, mainly through polyamine synthesis. Here we investigate the ability of the parasympathetic nervous system to modulate angiogenesis induced by TMps through the activation of the muscarinic acetylcholine receptor (mAchR). Methods Peritoneal macrophages from female BALB/c mice bearing a 7-day LMM3 tumor were inoculated intradermally (3 × 105 cells per site) into syngeneic mice. Before inoculation, TMps were stimulated with the muscarinic agonist carbachol in the absence or presence of different muscarinic antagonists or enzyme inhibitors. Angiogenesis was evaluated by counting vessels per square millimeter of skin. The expression of mAchR, arginase and cyclo-oxygenase (COX) isoforms was analyzed by Western blotting. Arginase and COX activities were evaluated by urea and prostaglandin E2 (PGE2) production, respectively. Results TMps, which stimulate neovascularization, express functional mAchR, because carbachol-treated TMps potently increased new blood vessels formation. This response was completely blocked by preincubating TMps with pirenzepine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), M1 and M3 receptor antagonists, and partly by the M2 receptor antagonist methoctramine. M1 receptor activation by carbachol in TMps triggers neovascularization through arginase products because N ω-hydroxy-L-arginine reversed the agonist action. Preincubation of TMps with methoctramine partly prevented carbachol-stimulated urea formation. In addition, COX-derived liberation of PGE2 is responsible for the promotion of TMps angiogenic activity by M3 receptor. We also detected a higher expression of vascular endothelial growth factor (VEGF) in TMps than in macrophages from normal mice. Carbachol significantly increased VEGF expression in TMps, and this effect was totally reversed by methoctramine and pirenzepine. Arginase and COX inhibitors partly decreased VEGF derived from TMps. Conclusion TMps themselves induce a potent angiogenic response that is augmented by carbachol action. mAchR activation triggers arginine metabolism, PGE2 synthesis and VEGF production, promoting neovascularization.Fil: de la Torre, Eulalia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaFil: Davel, Lilia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaFil: Jasnis, María A.. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaFil: Gotoh, Tomomi. Kumamoto University; JapónFil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Sales, María Elena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaUnidad documental simpleSpringer2006-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfnovalueArgentina[{ 'value':"",'auth':''}]Artículo científicoapplication/pdf-13de la Torre, Eulalia; Davel, Lilia; Jasnis, María A.; Gotoh, Tomomi; Sacerdote de Lustig, Eugenia; et al.; Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice; Springer; Breast Cancer Research; 7; 3; 8-2006; R345-R35215Alemania31Introduction The role of macrophages in tumor progression has generated contradictory evidence. We had previously demonstrated the ability of peritoneal macrophages from LMM3 murine mammary adenocarcinoma-bearing mice (TMps) to increase the angiogenicity of LMM3 tumor cells, mainly through polyamine synthesis. Here we investigate the ability of the parasympathetic nervous system to modulate angiogenesis induced by TMps through the activation of the muscarinic acetylcholine receptor (mAchR). Methods Peritoneal macrophages from female BALB/c mice bearing a 7-day LMM3 tumor were inoculated intradermally (3 × 105 cells per site) into syngeneic mice. Before inoculation, TMps were stimulated with the muscarinic agonist carbachol in the absence or presence of different muscarinic antagonists or enzyme inhibitors. Angiogenesis was evaluated by counting vessels per square millimeter of skin. The expression of mAchR, arginase and cyclo-oxygenase (COX) isoforms was analyzed by Western blotting. Arginase and COX activities were evaluated by urea and prostaglandin E2 (PGE2) production, respectively. Results TMps, which stimulate neovascularization, express functional mAchR, because carbachol-treated TMps potently increased new blood vessels formation. This response was completely blocked by preincubating TMps with pirenzepine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), M1 and M3 receptor antagonists, and partly by the M2 receptor antagonist methoctramine. M1 receptor activation by carbachol in TMps triggers neovascularization through arginase products because N ω-hydroxy-L-arginine reversed the agonist action. Preincubation of TMps with methoctramine partly prevented carbachol-stimulated urea formation. In addition, COX-derived liberation of PGE2 is responsible for the promotion of TMps angiogenic activity by M3 receptor. We also detected a higher expression of vascular endothelial growth factor (VEGF) in TMps than in macrophages from normal mice. Carbachol significantly increased VEGF expression in TMps, and this effect was totally reversed by methoctramine and pirenzepine. Arginase and COX inhibitors partly decreased VEGF derived from TMps. Conclusion TMps themselves induce a potent angiogenic response that is augmented by carbachol action. mAchR activation triggers arginine metabolism, PGE2 synthesis and VEGF production, promoting neovascularization.810273/submit/conicet/edit-metadata.jspOtroSpringerGuardar y salirhttps://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1005https://doi.org/10.1186/bcr1005accepted-1acceptedR345-R352novalueMuscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing miceinfo:eu-repo/semantics/reference/url/139371Berlín2006ADENOCARCINOMAMACROPHAGESSACERDOTE INVESTIGADORAPUBLICACIONESUnidad documental simpleinfo:eu-repo/semantics/altIdentifier/url/eng[{ 'value':"de la Torre, Eulalia",'auth':'21244','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]},{ 'value':"Davel, Lilia",'auth':'','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]},{ 'value':"Jasnis, María A.",'auth':'','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]},{ 'value':"Gotoh, Tomomi",'auth':'','org': [ {'value':"Kumamoto University",'auth':'','pais':'Japón','pais_id':'64'}]},{ 'value':"Sacerdote de Lustig, Eugenia",'auth':'3','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'},{'value':"Consejo Nacional de Investigaciones Científicas y Técnicas",'auth':'2565','pais':'Argentina','pais_id':'1'}]},{ 'value':"Sales, María Elena",'auth':'','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]}]info:eu-repo/semantics/altIdentifier/url/info:eu-repo/semantics/altIdentifier/doi/1465-542X1Breast Cancer Researchacceptedd4721328-1166-4ac4-829d-c85ec68a5dd1EscalaGrisc866c4ce-f1b5-4a9b-9914-b7bfaa2589e3600No especificaUniversidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"1141No especificaapplication/pdfhttp://hdl.handle.net/11336/122690de la Torre, Eulalia; Davel, Lilia; Jasnis, María A.; Gotoh, Tomomi; Sacerdote de Lustig, Eugenia; et al.; Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice; Springer; Breast Cancer Research; 7; 3; 8-2006; R345-R3521465-542Xenginfo:eu-repo/semantics/altIdentifier/url/https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1005info:eu-repo/semantics/altIdentifier/doi/10.1186/bcr1005info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:01:19Zoai:ri.conicet.gov.ar:11336/122690instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:01:19.908CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| title |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| spellingShingle |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice de la Torre, Eulalia ADENOCARCINOMA MACROPHAGES SACERDOTE INVESTIGADORA PUBLICACIONES |
| title_short |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| title_full |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| title_fullStr |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| title_full_unstemmed |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| title_sort |
Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice |
| dc.creator.none.fl_str_mv |
de la Torre, Eulalia Davel, Lilia Jasnis, María A. Gotoh, Tomomi Sacerdote de Lustig, Eugenia Sales, María Elena |
| author |
de la Torre, Eulalia |
| author_facet |
de la Torre, Eulalia Davel, Lilia Jasnis, María A. Gotoh, Tomomi Sacerdote de Lustig, Eugenia Sales, María Elena |
| author_role |
author |
| author2 |
Davel, Lilia Jasnis, María A. Gotoh, Tomomi Sacerdote de Lustig, Eugenia Sales, María Elena |
| author2_role |
author author author author author |
| dc.subject.none.fl_str_mv |
ADENOCARCINOMA MACROPHAGES SACERDOTE INVESTIGADORA PUBLICACIONES |
| topic |
ADENOCARCINOMA MACROPHAGES SACERDOTE INVESTIGADORA PUBLICACIONES |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Introduction The role of macrophages in tumor progression has generated contradictory evidence. We had previously demonstrated the ability of peritoneal macrophages from LMM3 murine mammary adenocarcinoma-bearing mice (TMps) to increase the angiogenicity of LMM3 tumor cells, mainly through polyamine synthesis. Here we investigate the ability of the parasympathetic nervous system to modulate angiogenesis induced by TMps through the activation of the muscarinic acetylcholine receptor (mAchR). Methods Peritoneal macrophages from female BALB/c mice bearing a 7-day LMM3 tumor were inoculated intradermally (3 × 105 cells per site) into syngeneic mice. Before inoculation, TMps were stimulated with the muscarinic agonist carbachol in the absence or presence of different muscarinic antagonists or enzyme inhibitors. Angiogenesis was evaluated by counting vessels per square millimeter of skin. The expression of mAchR, arginase and cyclo-oxygenase (COX) isoforms was analyzed by Western blotting. Arginase and COX activities were evaluated by urea and prostaglandin E2 (PGE2) production, respectively. Results TMps, which stimulate neovascularization, express functional mAchR, because carbachol-treated TMps potently increased new blood vessels formation. This response was completely blocked by preincubating TMps with pirenzepine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), M1 and M3 receptor antagonists, and partly by the M2 receptor antagonist methoctramine. M1 receptor activation by carbachol in TMps triggers neovascularization through arginase products because N ω-hydroxy-L-arginine reversed the agonist action. Preincubation of TMps with methoctramine partly prevented carbachol-stimulated urea formation. In addition, COX-derived liberation of PGE2 is responsible for the promotion of TMps angiogenic activity by M3 receptor. We also detected a higher expression of vascular endothelial growth factor (VEGF) in TMps than in macrophages from normal mice. Carbachol significantly increased VEGF expression in TMps, and this effect was totally reversed by methoctramine and pirenzepine. Arginase and COX inhibitors partly decreased VEGF derived from TMps. Conclusion TMps themselves induce a potent angiogenic response that is augmented by carbachol action. mAchR activation triggers arginine metabolism, PGE2 synthesis and VEGF production, promoting neovascularization. Fil: de la Torre, Eulalia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina Fil: Davel, Lilia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina Fil: Jasnis, María A.. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina Fil: Gotoh, Tomomi. Kumamoto University; Japón Fil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Sales, María Elena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina Unidad documental simple |
| description |
Introduction The role of macrophages in tumor progression has generated contradictory evidence. We had previously demonstrated the ability of peritoneal macrophages from LMM3 murine mammary adenocarcinoma-bearing mice (TMps) to increase the angiogenicity of LMM3 tumor cells, mainly through polyamine synthesis. Here we investigate the ability of the parasympathetic nervous system to modulate angiogenesis induced by TMps through the activation of the muscarinic acetylcholine receptor (mAchR). Methods Peritoneal macrophages from female BALB/c mice bearing a 7-day LMM3 tumor were inoculated intradermally (3 × 105 cells per site) into syngeneic mice. Before inoculation, TMps were stimulated with the muscarinic agonist carbachol in the absence or presence of different muscarinic antagonists or enzyme inhibitors. Angiogenesis was evaluated by counting vessels per square millimeter of skin. The expression of mAchR, arginase and cyclo-oxygenase (COX) isoforms was analyzed by Western blotting. Arginase and COX activities were evaluated by urea and prostaglandin E2 (PGE2) production, respectively. Results TMps, which stimulate neovascularization, express functional mAchR, because carbachol-treated TMps potently increased new blood vessels formation. This response was completely blocked by preincubating TMps with pirenzepine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), M1 and M3 receptor antagonists, and partly by the M2 receptor antagonist methoctramine. M1 receptor activation by carbachol in TMps triggers neovascularization through arginase products because N ω-hydroxy-L-arginine reversed the agonist action. Preincubation of TMps with methoctramine partly prevented carbachol-stimulated urea formation. In addition, COX-derived liberation of PGE2 is responsible for the promotion of TMps angiogenic activity by M3 receptor. We also detected a higher expression of vascular endothelial growth factor (VEGF) in TMps than in macrophages from normal mice. Carbachol significantly increased VEGF expression in TMps, and this effect was totally reversed by methoctramine and pirenzepine. Arginase and COX inhibitors partly decreased VEGF derived from TMps. Conclusion TMps themselves induce a potent angiogenic response that is augmented by carbachol action. mAchR activation triggers arginine metabolism, PGE2 synthesis and VEGF production, promoting neovascularization. |
| publishDate |
2006 |
| dc.date.none.fl_str_mv |
2006-08 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/122690 de la Torre, Eulalia; Davel, Lilia; Jasnis, María A.; Gotoh, Tomomi; Sacerdote de Lustig, Eugenia; et al.; Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice; Springer; Breast Cancer Research; 7; 3; 8-2006; R345-R352 1465-542X |
| url |
http://hdl.handle.net/11336/122690 |
| identifier_str_mv |
de la Torre, Eulalia; Davel, Lilia; Jasnis, María A.; Gotoh, Tomomi; Sacerdote de Lustig, Eugenia; et al.; Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice; Springer; Breast Cancer Research; 7; 3; 8-2006; R345-R352 1465-542X |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1005 info:eu-repo/semantics/altIdentifier/doi/10.1186/bcr1005 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf novalue Argentina [{ 'value':"",'auth':''}] Artículo científico application/pdf -1 3 de la Torre, Eulalia; Davel, Lilia; Jasnis, María A.; Gotoh, Tomomi; Sacerdote de Lustig, Eugenia; et al.; Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice; Springer; Breast Cancer Research; 7; 3; 8-2006; R345-R352 15 Alemania 31 Introduction The role of macrophages in tumor progression has generated contradictory evidence. We had previously demonstrated the ability of peritoneal macrophages from LMM3 murine mammary adenocarcinoma-bearing mice (TMps) to increase the angiogenicity of LMM3 tumor cells, mainly through polyamine synthesis. Here we investigate the ability of the parasympathetic nervous system to modulate angiogenesis induced by TMps through the activation of the muscarinic acetylcholine receptor (mAchR). Methods Peritoneal macrophages from female BALB/c mice bearing a 7-day LMM3 tumor were inoculated intradermally (3 × 105 cells per site) into syngeneic mice. Before inoculation, TMps were stimulated with the muscarinic agonist carbachol in the absence or presence of different muscarinic antagonists or enzyme inhibitors. Angiogenesis was evaluated by counting vessels per square millimeter of skin. The expression of mAchR, arginase and cyclo-oxygenase (COX) isoforms was analyzed by Western blotting. Arginase and COX activities were evaluated by urea and prostaglandin E2 (PGE2) production, respectively. Results TMps, which stimulate neovascularization, express functional mAchR, because carbachol-treated TMps potently increased new blood vessels formation. This response was completely blocked by preincubating TMps with pirenzepine and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP), M1 and M3 receptor antagonists, and partly by the M2 receptor antagonist methoctramine. M1 receptor activation by carbachol in TMps triggers neovascularization through arginase products because N ω-hydroxy-L-arginine reversed the agonist action. Preincubation of TMps with methoctramine partly prevented carbachol-stimulated urea formation. In addition, COX-derived liberation of PGE2 is responsible for the promotion of TMps angiogenic activity by M3 receptor. We also detected a higher expression of vascular endothelial growth factor (VEGF) in TMps than in macrophages from normal mice. Carbachol significantly increased VEGF expression in TMps, and this effect was totally reversed by methoctramine and pirenzepine. Arginase and COX inhibitors partly decreased VEGF derived from TMps. Conclusion TMps themselves induce a potent angiogenic response that is augmented by carbachol action. mAchR activation triggers arginine metabolism, PGE2 synthesis and VEGF production, promoting neovascularization. 8 10273 /submit/conicet/edit-metadata.jsp Otro Springer Guardar y salir https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr1005 https://doi.org/10.1186/bcr1005 accepted -1 accepted R345-R352 novalue Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice info:eu-repo/semantics/reference/url/ 1393 7 1 Berlín 2006 ADENOCARCINOMA MACROPHAGES SACERDOTE INVESTIGADORA PUBLICACIONES Unidad documental simple info:eu-repo/semantics/altIdentifier/url/ eng [{ 'value':"de la Torre, Eulalia",'auth':'21244','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]},{ 'value':"Davel, Lilia",'auth':'','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]},{ 'value':"Jasnis, María A.",'auth':'','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]},{ 'value':"Gotoh, Tomomi",'auth':'','org': [ {'value':"Kumamoto University",'auth':'','pais':'Japón','pais_id':'64'}]},{ 'value':"Sacerdote de Lustig, Eugenia",'auth':'3','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'},{'value':"Consejo Nacional de Investigaciones Científicas y Técnicas",'auth':'2565','pais':'Argentina','pais_id':'1'}]},{ 'value':"Sales, María Elena",'auth':'','org': [ {'value':'Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"','auth':'1393','pais':'Argentina','pais_id':'1'}]}] info:eu-repo/semantics/altIdentifier/url/ info:eu-repo/semantics/altIdentifier/doi/ 1465-542X 1 Breast Cancer Research accepted d4721328-1166-4ac4-829d-c85ec68a5dd1 EscalaGris c866c4ce-f1b5-4a9b-9914-b7bfaa2589e3 600 No especifica Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo" 1 141 No especifica application/pdf |
| dc.publisher.none.fl_str_mv |
Springer |
| publisher.none.fl_str_mv |
Springer |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1846782344712683520 |
| score |
12.982451 |